PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q4 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $461,194 | +116.4% | 158,486 | +117.1% | 0.00% | – |
| Q4 2022 | $213,160 | -28.5% | 73,000 | -41.2% | 0.00% | – |
| Q3 2022 | $298,000 | -43.1% | 124,124 | -46.5% | 0.00% | – |
| Q2 2022 | $524,000 | +219.5% | 231,809 | +226.2% | 0.00% | – |
| Q1 2022 | $164,000 | +15.5% | 71,062 | +24.7% | 0.00% | – |
| Q4 2021 | $142,000 | +49.5% | 57,000 | +89.4% | 0.00% | – |
| Q3 2021 | $95,000 | – | 30,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |